Inhibition of G1 to S phase progression by a novel zinc finger protein P58TFL at P-bodies

Molecular Cancer Research

Volumn 7, Issue 6, 2009, Pages 880-889

  Minagawa, Kentaro ^a   Katayama, Yoshio ^a   Nishikawa, Shinichiro ^a   Yamamoto, Katsuya ^a   Sada, Akiko ^a   Okamura, Atsuo ^a   Shimoyama, Manabu ^a   Matsui, Toshimitsu ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; EUKARYOTIC TRANSLATION INITIATION FACTOR 2C; GENE PRODUCT; INITIATION FACTOR; PROTEIN P 36; PROTEIN P54; RETINOBLASTOMA PROTEIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN 1; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; CYTOPLASM; DISEASE MARKER; DNA SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA PROCESSING; SUPPRESSOR GENE; TFL GENE; ZINC FINGER MOTIF;

ANIMALS; APOPTOSIS; BLOOD PROTEINS; CASPASE 3; CELL GROWTH PROCESSES; CELL LINE; CELL LINE, TUMOR; DNA; G1 PHASE; GENE EXPRESSION PROFILING; HUMANS; INTERPHASE; INTRACELLULAR SPACE; JURKAT CELLS; LEUKEMIA; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; RECOMBINANT PROTEINS; RETINOBLASTOMA PROTEIN; RNA SPLICING; RNA, MESSENGER; S PHASE; TUMOR SUPPRESSOR PROTEINS; ZINC FINGERS;

EUKARYOTA;

EID: 67649576725     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0511     Document Type: Article

References (48)

1. Frohling S, Dohner H. Chromosomal abnormalities in cancer. N Engl J Med 2008;359:722-734
2. Licht JD, Sternberg DW. The molecular pathology of acute myeloid leukemia. Hematol Am Soc Hematol Educ Program 2005;137-142
3. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005;5:251-262 (Pubitemid 40488631)
4. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359:162-165
5. Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007;448:561-566 (Pubitemid 47206930)
6. Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-293
7. Goldman JM, Melo JV. Chronic myeloid leukemia - advances in biology and new approaches to treatment. N Engl J Med 2003;349:1451-1464
8. Rowley JD. Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation. J Clin Oncol 1988;6:919-925 (Pubitemid 18124775)
9. Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ, Adomat SA. Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. Am J Clin Pathol 1995;103:472-478
10. Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia 2007;21:18-29. (Pubitemid 44921830)
11. Zhang Y, Matthiesen P, Siebert R, et al. Detection of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization. Hum Genet 1998;103:727-729 (Pubitemid 29020772)
12. Bailey-Wilson JE, Amos CI, Pinney SM, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004;75:460-474 (Pubitemid 39095821)
13. Tilly H, Rossi A, Stamatoullas A, et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994;84:1043-1049 (Pubitemid 24245867)
14. Offit K, Parsa NZ, Gaidano G, et al. 6q deletions define distinct clinicopathologic subsets of non-Hodgkin's lymphoma. Blood 1993;82:2157-2162 (Pubitemid 23294000)
15. Cheung KJ, Shah SP, Steidl C, et al. Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood 2008.
16. Viardot A, Moller P, Hogel J, et al. Clinicopathologic correlations of genomic gains and losses in follicular lymphoma. J Clin Oncol 2002;20:4523-4530 (Pubitemid 35402955)
17. Zhang L, Anglesio MS, O'Sullivan M, et al. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers. Nat Med 2007;13:1060-1069 (Pubitemid 47517503)
18. Anglesio MS, Evdokimova V, Melnyk N, et al. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney. Hum Mol Genet 2004;13:2061-2074 (Pubitemid 39377829)
19. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-1214 (Pubitemid 36359296)
20. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008;22:14-22.
21. Yamamoto K, Okamura A, Minagawa K, et al. A novel t(2;6)(p12;q23) appearing during transformation of follicular lymphoma with t(18;22)(q21; q11) to diffuse large cell lymphoma. Cancer Genet Cytogenet 2003;147:128-133 (Pubitemid 37414871)
22. Minagawa K, Yamamoto K, Nishikawa S, et al. Deregulation of a possible tumour suppressor gene, ZC3H12D, by translocation of IGK@ in transformed follicular lymphoma with t(2;6)(p12;q25). Br J Haematol 2007;139:161-163 (Pubitemid 47389927)
23. Wang M, Vikis HG, Wang Y, et al. Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. Cancer Res 2007;67:93-99 (Pubitemid 46142763)
24. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-1677 (Pubitemid 26414890)
25. Sen GL, Blau HM. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 2005;7:633-636 (Pubitemid 40796987)
26. Cougot N, Babajko S, Seraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol 2004;165:31-40. (Pubitemid 38649174)
27. Kedersha N, Stoecklin G, Ayodele M, et al. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 2005;169:871-884 (Pubitemid 41002864)
28. Wilczynska A, Aigueperse C, Kress M, Dautry F, Weil D. The translational regulator CPEB1 provides a link between dcp1 bodies and stress granules. J Cell Sci 2005;118:981-992 (Pubitemid 40484888)
29. Christoforidis S, McBride HM, Burgoyne RD, Zerial M. The Rab5 effector EEA1 is a core component of endosome docking. Nature 1999;397:621-625 (Pubitemid 29091948)
30. Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S. LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J 2007;26:313-324 (Pubitemid 46160933)
31. Liang J, Song W, Tromp G, Kolattukudy PE, Fu M. Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation. PLoS ONE 2008;3:e2880.
32. Liang J, Wang J, Azfer A, et al. A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J Biol Chem 2008;283:6337-6346
33. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 1998;281:1001-1005 (Pubitemid 28399252)
34. McDonnell TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989;57:79-88. (Pubitemid 19098870)
35. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990;144:3602-3610 (Pubitemid 20146400)
36. Knudsen ES, Wang JY. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 1997;17:5771-5783 (Pubitemid 27411084)
37. Zhou L, Azfer A, Niu J, et al. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ Res 2006;98:1177-1185 (Pubitemid 43948104)
38. Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999;17:781-828. (Pubitemid 29241140)
39. Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods 2000;243:167-190 (Pubitemid 30734601)
40. Barreau C, Paillard L, Osborne HB. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 2005;33:7138-7150
41. Vasudevan S, Steitz JA. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 2007;128:1105-1118 (Pubitemid 46427873)
42. Eulalio A, Behm-Ansmant I, Izaurralde E. P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 2007;8:9-22. (Pubitemid 46012011)
43. Vinuesa CG, Cook MC, Angelucci C, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005;435:452-458 (Pubitemid 40734237)
44. Yu D, Tan AH, Hu X, et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007;450:299-303. (Pubitemid 350100535)
45. Niu J, Azfer A, Zhelyabovska O, Fatma S, Kolattukudy PE. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J Biol Chem 2008;283:14542-14551
46. Okamura A, Iwata N, Nagata A, et al. Involvement of casein kinase Iε in cytokine-induced granulocytic differentiation. Blood 2004;103:2997-3004. (Pubitemid 38451672)
47. Iwata N, Murayama T, Matsumori Y, et al. Autocrine loop through cholecystokinin-B/gastrin receptors involved in growth of human leukemia cells. Blood 1996;88:2683-2689 (Pubitemid 26327521)
48. Rodriguez-Tarduchy G, Collins M, Lopez-Rivas A. Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J 1990;9:2997-3002. (Pubitemid 20278763)